People | April 20, 2026
Novartis CEO Vas Narasimhan joins Anthropic board
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
Move strengthens footprint in Western India and expands multi-specialty care network
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
Bidding window open till May 15; study to map costs and bottlenecks across pharma supply chains
The programme is being implemented in collaboration with Grow Well Foundation and is expected to expand in a phased manner
The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
Subscribe To Our Newsletter & Stay Updated
